Articles
12 March 2025
Early Access
Mendelian randomization analysis of the causal association between metabolite and skin cancer
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
184
Views
191
Downloads
Authors
Skin cancer (SC) is a significant public health issue, with increasing incidence rates globally. Although environmental factors such as ultraviolet (UV) exposure are recognized risk factors, the impact of metabolites on SC development has not been thoroughly examined. This study seeks to explore the causal association between metabolites and SC risks using a Mendelian randomization (MR) approach. Our analysis revealed a total of 76 metabolites associated with SC risk. Of them, leucine to N-palmitoyl-sphingosine ratio, glycerol to palmitoylcarnitine ratio, oleoyl-linoleoyl-glycerol levels, and hypotaurine-to-taurine ratio were strongly associated with SC. Notably, leucine to N-palmitoyl-sphingosine ratio and glycerol to palmitoylcarnitine ratio were linked to increased risk factors for SC. However, oleoyl-linoleoyl-glycerol levels and hypotaurine-to-taurine ratio served as the protective indicators of SC. This study highlights the potential role of metabolites in skin cancer etiology, suggesting that metabolic factors may serve as important targets for prevention and risk assessment strategies.
Altmetrics
Downloads
Download data is not yet available.
Citations
Chandra J, Hasan N, Nasir N, et al. Nanotechnology-empowered strategies in treatment of skin cancer. Environ Res 2023;235:116649. DOI: https://doi.org/10.1016/j.envres.2023.116649
Hasan N, Nadaf A, Imran M, et al. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. Mol Cancer 2023;22:168. DOI: https://doi.org/10.1186/s12943-023-01854-3
Tang X, Yang T, Yu D, et al. Current insights and future perspectives of ultraviolet radiation (UV) exposure: Friends and foes to the skin and beyond the skin. Environ Int 2024;185:108535. DOI: https://doi.org/10.1016/j.envint.2024.108535
Salgado Kiefer YCS, Ferreira MB, da Luz JZ, et al. Glyphosate and aminomethylphosphonic acid metabolite (AMPA) modulate the phenotype of murine melanoma B16-F1 cells. Environ Toxicol Pharmacol 2024;107:104429. DOI: https://doi.org/10.1016/j.etap.2024.104429
Nov P, Zheng C, Wang D, et al. Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study. Mol Med Rep 2024;30. DOI: https://doi.org/10.3892/mmr.2024.13336
Agarwala SS, Kirkwood JM. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist 2000;5:144-51. DOI: https://doi.org/10.1634/theoncologist.5-2-144
Ang JE, Pal A, Asad YJ, et al. Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma. Mol Cancer Ther 2017;16:2315-23. DOI: https://doi.org/10.1158/1535-7163.MCT-16-0881
Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Gen 2014;23:R89-98. DOI: https://doi.org/10.1093/hmg/ddu328
Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22. DOI: https://doi.org/10.1093/ije/dyg070
Adewuyi EO, O'Brien EK, Porter T, et al. Relationship of Cognition and Alzheimer's Disease with Gastrointestinal Tract Disorders: A Large-Scale Genetic Overlap and Mendelian Randomisation Analysis. Int J Mol Sci 2022;23. DOI: https://doi.org/10.21203/rs.3.rs-1931535/v2
Gyamfi J, Kim J, Choi J. Cancer as a Metabolic Disorder. Int J Mol Sci 2022;23. DOI: https://doi.org/10.3390/ijms23031155
Li C, Zhang G, Zhao L, et al. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J Surg Oncol 2016;14:15. DOI: https://doi.org/10.1186/s12957-016-0769-9
Liu M, Zhang Z, Chen Y, et al. Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer. Front Endocrinol 2023;14:1292011. DOI: https://doi.org/10.3389/fendo.2023.1292011
Xu H, Wang X, Xu X, et al. Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis. Clin Nutr (Edinburgh, Scotland) 2023;42:2493-502. DOI: https://doi.org/10.1016/j.clnu.2023.10.019
Chen J, Liu X, Zou Y, et al. A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation. Proc Natl Acad Sci USA 2024;121:e2306776121. DOI: https://doi.org/10.1073/pnas.2306776121
Otsuki H, Kimura T, Yamaga T, et al. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters. Prostate 2017;77:222-33. DOI: https://doi.org/10.1002/pros.23263
Chamcheu JC, Roy T, Uddin MB, et al. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy. Cells 2019;8. DOI: https://doi.org/10.3390/cells8080803
Bouhours JF, Guignard H. Free ceramide, sphingomyelin, and glucosylceramide of isolated rat intestinal cells. J Lipid Res 1979;20:879-907. DOI: https://doi.org/10.1016/S0022-2275(20)40019-7
Telleria O, Alboniga OE, Clos-Garcia M, et al. A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients. Metabolites 2022;12. DOI: https://doi.org/10.3390/metabo12060550
Lebeck J. Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver. J Mol Endocrinol 2014;52:R165-78. DOI: https://doi.org/10.1530/JME-13-0268
Li Z, Li B, Zhang L, et al. The proliferation impairment induced by AQP3 deficiency is the result of glycerol uptake and metabolism inhibition in gastric cancer cells. Tumour Biol 2016;37:9169-79. DOI: https://doi.org/10.1007/s13277-015-4753-8
Lorenzetti F, Capiglioni AM, Marinelli RA, et al. Hepatic glycerol metabolism is early reprogrammed in rat liver cancer development. Biochimie 2020;170:88-93. DOI: https://doi.org/10.1016/j.biochi.2020.01.002
Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994;91:6379-83. DOI: https://doi.org/10.1073/pnas.91.14.6379
Al-Bakheit A, Traka M, Saha S, et al. Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer. Prostate 2016;76:1326-37. DOI: https://doi.org/10.1002/pros.23222
Turnbull PC, Hughes MC, Perry CGR. The fatty acid derivative palmitoylcarnitine abrogates colorectal cancer cell survival by depleting glutathione. Am J Physiol Cell Physiol 2019;317:C1278-88. DOI: https://doi.org/10.1152/ajpcell.00319.2019
Dong T, Wang X, Jia Z, et al. Assessing the associations of 1,400 blood metabolites with major depressive disorder: a Mendelian randomization study. Front Psychiatry 2024;15:1391535. DOI: https://doi.org/10.3389/fpsyt.2024.1391535
Stipanuk MH, Ueki I. Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis 2011;34:17-32. DOI: https://doi.org/10.1007/s10545-009-9006-9
Jiang XR, Yang M, Morris CJ, et al. High field proton NMR investigations of the metabolic profiles of multidrug-sensitive and -resistant leukaemic cell lines: evidence for diminished taurine levels in multidrug-resistant cells. Free Radic Res Commun 1993;19:355-69. DOI: https://doi.org/10.3109/10715769309056526
Baseggio Conrado A, Fanelli S, McGuire VA, et al. Role of Hypotaurine in Protection against UVA-Induced Damage in Keratinocytes. Photochem Photobiol 2021;97:353-9. DOI: https://doi.org/10.1111/php.13334
Ma N, He F, Kawanokuchi J, et al. Taurine and Its Anticancer Functions: In Vivo and In Vitro Study. Adv Exp Med Biol 2022;1370:121-8. DOI: https://doi.org/10.1007/978-3-030-93337-1_11
How to Cite
Mendelian randomization analysis of the causal association between metabolite and skin cancer. (2025). Dermatology Reports. https://doi.org/10.4081/dr.2025.10159
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
